These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 28618199)

  • 1. Lipid interactions modulate the structural and antigenic properties of the C-terminal domain of the malaria antigen merozoite surface protein 2.
    Das SC; Morales RAV; Seow J; Krishnarjuna B; Dissanayake R; Anders RF; MacRaild CA; Norton RS
    FEBS J; 2017 Aug; 284(16):2649-2662. PubMed ID: 28618199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and Characterisation of a Key Epitope in the Conserved C-Terminal Domain of the Malaria Vaccine Candidate MSP2.
    Seow J; Morales RA; MacRaild CA; Krishnarjuna B; McGowan S; Dingjan T; Jaipuria G; Rouet R; Wilde KL; Atreya HS; Richards JS; Anders RF; Christ D; Drinkwater N; Norton RS
    J Mol Biol; 2017 Mar; 429(6):836-846. PubMed ID: 28189425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational dynamics and antigenicity in the disordered malaria antigen merozoite surface protein 2.
    MacRaild CA; Zachrdla M; Andrew D; Krishnarjuna B; Nováček J; Žídek L; Sklenář V; Richards JS; Beeson JG; Anders RF; Norton RS
    PLoS One; 2015; 10(3):e0119899. PubMed ID: 25742002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic characterization of an intrinsically unstructured protein, Plasmodium falciparum merozoite surface protein 2.
    Adda CG; MacRaild CA; Reiling L; Wycherley K; Boyle MJ; Kienzle V; Masendycz P; Foley M; Beeson JG; Norton RS; Anders RF
    Infect Immun; 2012 Dec; 80(12):4177-85. PubMed ID: 22966050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid interactions of the malaria antigen merozoite surface protein 2.
    MacRaild CA; Pedersen MØ; Anders RF; Norton RS
    Biochim Biophys Acta; 2012 Nov; 1818(11):2572-8. PubMed ID: 22749949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposome engraftment and antigen combination potentiate the immune response towards conserved epitopes of the malaria vaccine candidate MSP2.
    Das SC; Price JD; Gosling K; MacLennan N; Ataíde R; Seow J; Irani V; Atmosukarto II; Anders RF; Richards JS; MacRaild CA; Norton RS
    Vaccine; 2021 Mar; 39(12):1746-1757. PubMed ID: 33618946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for epitope masking and strain specificity of a conserved epitope in an intrinsically disordered malaria vaccine candidate.
    Morales RAV; MacRaild CA; Seow J; Krishnarjuna B; Drinkwater N; Rouet R; Anders RF; Christ D; McGowan S; Norton RS
    Sci Rep; 2015 May; 5():10103. PubMed ID: 25965408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the helical structure of the N-terminal region of Plasmodium falciparum merozoite surface protein 2 in fibril formation and membrane interaction.
    Zhang X; Adda CG; Low A; Zhang J; Zhang W; Sun H; Tu X; Anders RF; Norton RS
    Biochemistry; 2012 Feb; 51(7):1380-7. PubMed ID: 22304430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution conformation, backbone dynamics and lipid interactions of the intrinsically unstructured malaria surface protein MSP2.
    Zhang X; Perugini MA; Yao S; Adda CG; Murphy VJ; Low A; Anders RF; Norton RS
    J Mol Biol; 2008 May; 379(1):105-21. PubMed ID: 18440022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A partially structured region of a largely unstructured protein, Plasmodium falciparum merozoite surface protein 2 (MSP2), forms amyloid-like fibrils.
    Yang X; Adda CG; Keizer DW; Murphy VJ; Rizkalla MM; Perugini MA; Jackson DC; Anders RF; Norton RS
    J Pept Sci; 2007 Dec; 13(12):839-48. PubMed ID: 17883245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Merozoite surface protein 2 of Plasmodium falciparum: expression, structure, dynamics, and fibril formation of the conserved N-terminal domain.
    Low A; Chandrashekaran IR; Adda CG; Yao S; Sabo JK; Zhang X; Soetopo A; Anders RF; Norton RS
    Biopolymers; 2007 Sep; 87(1):12-22. PubMed ID: 17516503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2.
    Krishnarjuna B; Andrew D; MacRaild CA; Morales RA; Beeson JG; Anders RF; Richards JS; Norton RS
    Sci Rep; 2016 Feb; 6():20613. PubMed ID: 26865062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key residues involved in fibril formation by the conserved N-terminal region of Plasmodium falciparum merozoite surface protein 2 (MSP2).
    Yang X; Adda CG; MacRaild CA; Low A; Zhang X; Zeng W; Jackson DC; Anders RF; Norton RS
    Biochimie; 2010 Oct; 92(10):1287-95. PubMed ID: 20542076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum merozoite surface protein 2: epitope mapping and fine specificity of human antibody response against non-polymorphic domains.
    Balam S; Olugbile S; Servis C; Diakité M; D'Alessandro A; Frank G; Moret R; Nebie I; Tanner M; Felger I; Smith T; Kajava AV; Spertini F; Corradin G
    Malar J; 2014 Dec; 13():510. PubMed ID: 25526742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium falciparum merozoite surface protein 2 is unstructured and forms amyloid-like fibrils.
    Adda CG; Murphy VJ; Sunde M; Waddington LJ; Schloegel J; Talbo GH; Vingas K; Kienzle V; Masciantonio R; Howlett GJ; Hodder AN; Foley M; Anders RF
    Mol Biochem Parasitol; 2009 Aug; 166(2):159-71. PubMed ID: 19450733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the aggregation of an amyloidogenic sequence by flanking-disordered region in the intrinsically disordered antigen merozoite surface protein 2.
    Zhang W; Zhang J; MacRaild CA; Norton RS; Anders RF; Zhang X
    Eur Biophys J; 2019 Jan; 48(1):99-110. PubMed ID: 30443712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of dimorphic and C-terminal fragments of Plasmodium falciparum MSP2 formulated with different adjuvants in mice.
    Balam S; Jafarshad A; Servis C; Frank G; Reed S; Pink R; Druilhe P; Spertini F; Corradin G
    Vaccine; 2016 Mar; 34(13):1566-1574. PubMed ID: 26874325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
    Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
    Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum.
    Wang L; Black CG; Marshall VM; Coppel RL
    Infect Immun; 1999 May; 67(5):2193-200. PubMed ID: 10225874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720.
    McCarthy JS; Marjason J; Elliott S; Fahey P; Bang G; Malkin E; Tierney E; Aked-Hurditch H; Adda C; Cross N; Richards JS; Fowkes FJ; Boyle MJ; Long C; Druilhe P; Beeson JG; Anders RF
    PLoS One; 2011; 6(9):e24413. PubMed ID: 21949716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.